Antiherpesvirus drugs: a promising spectrum of new drugs and drug targets
- 1 April 2003
- journal article
- review article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 2 (4) , 278-288
- https://doi.org/10.1038/nrd1065
Abstract
In the absence of effective vaccines to control herpesvirus infections, nucleosidic antiviral drugs have been the mainstay of clinical treatment since their development in the late 1970s. However, given the drawbacks of these drugs, including the increasing emergence of drug-resistant clinical isolates, new strategies for treating herpesvirus infections are warranted. A range of promising new drugs with novel molecular targets has been developed, but will they cure latent infections?Keywords
This publication has 70 references indexed in Scilit:
- Inhibition of host kinase activity altered by the LMP2A signalosome—a therapeutic target for Epstein–Barr virus latency and associated diseaseAntiviral Research, 2002
- Inhibition of Herpes Simplex Virus Replication by WAY-150138: Assembly of Capsids Depleted of the Portal and Terminase Proteins Involved in DNA EncapsidationJournal of Virology, 2002
- Potent and Selective Inhibition of Human Cytomegalovirus Replication by 1263W94, a Benzimidazole l -Riboside with a Unique Mode of ActionAntimicrobial Agents and Chemotherapy, 2002
- Pharmacological Cyclin-Dependent Kinase Inhibitors Inhibit Replication of Wild-Type and Drug-Resistant Strains of Herpes Simplex Virus and Human Immunodeficiency Virus Type 1 by Targeting Cellular, Not Viral, ProteinsJournal of Virology, 2002
- Herpes simplex virus glycoprotein D bound to the human receptor HveA.Published by Elsevier ,2001
- Identification of Crucial Hydrogen-Bonding Residues for the Interaction of Herpes Simplex Virus DNA Polymerase Subunits via Peptide Display, Mutational, and Calorimetric ApproachesJournal of Virology, 2001
- Unique fold and active site in cytomegalovirus proteaseNature, 1996
- A new serine-protease fold revealed by the crystal structure of human cytomegalovirus proteaseNature, 1996
- Role of the Carboxy Terminus of Herpes Simplex Virus Type 1 DNA Polymerase in its Interaction With UL42Journal of General Virology, 1994
- Live Attenuated Varicella Virus VaccineNew England Journal of Medicine, 1984